NIPT

Apr 25, 2022

Yourgene Health, Ambry Genetics Team on Genomic Services Under Extended Strategic Partnership

Apr 20, 2022

FDA Cautions of False Results From Prenatal Genetic Tests

Mar 30, 2022

BillionToOne Raises $125M in Series C Funding Round

Mar 9, 2022

Natera Refutes Claims in Short Seller Report After Stock Plummets

Feb 25, 2022

Natera Hit With Multiple Class Action Suits Over 'Unreliable' NIPT Results

Dec 9, 2021

Medicover to Buy €44.4M in NIPD Shares, Acquire Majority Stake

Nov 19, 2021

Natera Accused of Unfair, Deceptive Billing Practices Related to NIPT Services in New Lawsuit

Nov 15, 2021

Sema4 Q3 Revenues Rise 12 Percent

Aug 11, 2021

Yourgene Health Q1 Preliminary Revenues Rise 80 Percent

Aug 10, 2021

Progenity, Natera Jointly Request Dismissal of Patent Litigation

Jul 22, 2021

Sema4 Closes SPAC Deal With CM Life Sciences, Raising Approximately $500M
Premium

Jul 13, 2021

Natera Inks Distribution Deal With TomaLab for Italy

Jul 1, 2021

BillionToOne Adapting Fetal Dx Tech for Liquid Biopsy, Cancer Therapy Response Monitoring
Premium

Jun 14, 2021

BillionToOne Raises $55M in Series B Financing

Jun 2, 2021

Progenity to Close Genetics Lab as Focus Shifts to Therapeutics

May 26, 2021

Illumina, Roche Agree to Settle NIPT Patent Lawsuits

May 19, 2021

Yourgene, Alliance Global Sign Distribution Deal for Middle East, Africa

May 3, 2021

Echelon Diagnostics, Cradle Genomics Ink Noninvasive Prenatal Diagnostics Partnership

Apr 14, 2021

Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood
Premium

Mar 18, 2021

Progenity Q4 Revenues Fall 30 Percent on COVID-19 Effect